The role and clinical value of EUS in a multimodality esophageal carcinoma staging program with CT and positron emission tomography
| Autor: | Tracey L. Weigel, Peter Stanko, Patrick R. Pfau, Terrence J. Frick, Scott B. Perlman, Deepak V. Gopal, Zhengjun Zhang, Adnan Said |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male medicine.medical_specialty Esophageal Neoplasms Biopsy medicine.medical_treatment Adenocarcinoma Endosonography Metastasis Diagnosis Differential Preoperative Care medicine Humans Radiology Nuclear Medicine and imaging Neoplasm Metastasis Esophagus Neoadjuvant therapy Aged Neoplasm Staging Retrospective Studies Cancer staging Aged 80 and over medicine.diagnostic_test Esophageal disease business.industry Gastroenterology Middle Aged Esophageal cancer Prognosis medicine.disease Primary tumor digestive system diseases medicine.anatomical_structure Positron emission tomography Positron-Emission Tomography Carcinoma Squamous Cell Female Radiology Tomography X-Ray Computed business Follow-Up Studies |
| Zdroj: | Gastrointestinal Endoscopy. 65:377-384 |
| ISSN: | 0016-5107 |
| DOI: | 10.1016/j.gie.2006.12.015 |
| Popis: | Background EUS, CT, and positron emission tomography (PET) have all been used in the preoperative staging of esophageal cancer separately or in various combinations. Objective Our purpose was to determine the value and role of EUS when used in conjunction with CT and PET imaging in staging cancer of the esophagus and gastroesophageal junction. Design Retrospective single-center clinical trial. Setting Academic tertiary care center. Patients Data were examined for 56 patients who concomitantly underwent examination with EUS, CT, and PET in a multimodality staging program. Main Outcome Measurements EUS, CT, and PET were examined for their ability to detect the primary tumor, local tumor stage, locoregional adenopathy, and distant metastases. With use of surgical resection as baseline therapy, the frequency at which EUS, CT, and PET affected and changed management was examined. Results EUS is the only imaging test that identified all primary tumors and provided tumor staging. EUS identified a significantly greater number of patients (58.9%) with locoregional nodes than did CT (26.8%), P = .0006, or PET (37.5%), P = .02. CT identified 14.3% and PET identified 26.8% of patients with distant metastases. With CT alone, 15.2% of patients were not taken to surgery, whereas PET affected management by preventing surgery because of metastatic disease in 28.3% of patients. EUS changed management by guiding the need for neoadjuvant therapy in 34.8% of patients. Limitations Retrospective study, nonblinded study, lack of pathologic reference standard. Conclusion The primary strength of EUS in a multimodality staging strategy is in identifying patients with locally advanced disease and guiding the need for preoperative neoadjuvant therapy. EUS is not suited to determine resectability of esophageal cancer alone and thus is most effective when used in conjunction with other imaging tests such as CT and PET. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect